Investors

Shareholder information

Information for our shareholders, including significant shareholdings and advisors

Shareholder Information

Corporate Goverance

How we comply with the QCA code

Corporate Governance
AR_Mockup_320x181.png

Results, Reports and Presentations

View our latest releases

Latest reports
AR_Mockup_320x181.png

AIM Rule 26

Details required under Aim rule 26

AIM Rule 26

RNS alerts

20 Feb 2019 Notice of Results
03 Jan 2019 Director Shareholding

Email alerts

Partnering & Collaboration

Our NDD approach consistently generates potent and novel hits, assisting companies increase the productivity of their drug discovery.

Please get in touch at bd@etherapeutics.co.uk.